Trials / Completed
CompletedNCT05624853
A Randomized, Active-controlled, Parallel, Open-label, Multicenter, Phase 4 Study to Compare the Efficacy and Safety of Pregabalin Sustained Release Tablet and Pregabalin Immediate Release Capsule in Type II Diabetic Patients With Peripheral Neuropathic Pain
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 130 (actual)
- Sponsor
- Yuhan Corporation · Industry
- Sex
- All
- Age
- 19 Years – 74 Years
- Healthy volunteers
- Not accepted
Summary
This study is to compare the efficacy and safety of pregabalin sustained release tablet and pregabalin immediate release capsule in type II diabetic patients with peripheral neuropathic pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | pregabalin sustained release tablet | pregabalin sustained release tablet 150mg qd for 8weeks |
| DRUG | pregabalin immediate release capsule | pregabalin immediate release capsule 75mg bid for 8weeks |
Timeline
- Start date
- 2020-05-12
- Primary completion
- 2022-12-20
- Completion
- 2022-12-20
- First posted
- 2022-11-22
- Last updated
- 2023-10-23
Locations
8 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05624853. Inclusion in this directory is not an endorsement.